gms | German Medical Science

10th Munich Vascular Conference

01.-03.12.2021, online

Primary patency rate of native vessel revascularization after failed femoropopliteal bypass surgery

Meeting Abstract

Suche in Medline nach

  • corresponding author presenting/speaker Mohamed Rizk - Faculty of Medicine, Ain Shams University, Cairo, Egypt

10th Munich Vascular Conference. sine loco [digital], 01.-03.12.2021. Düsseldorf: German Medical Science GMS Publishing House; 2021. Doc27

doi: 10.3205/21mac27, urn:nbn:de:0183-21mac270

Veröffentlicht: 22. Dezember 2021

© 2021 Rizk.
Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung). Lizenz-Angaben siehe



Background: Treating patients with chronic limb threating ischemia, who has had failed femoropopliteal bypass represents a challenge, because those patients are having TASC C or D lesions and may not be good candidates for surgical intervention. Endovascular intervention may offer a suitable solution.

Methods: A retrospective case series of 34 patients presenting with chronic limb threating ischemia and previously failed femoropopliteal bypass, they were subjected to native vessel revascularization through a contralateral approach with balloon dilatation and stenting on demand of the superficial femoral artery (SFA).

Results: Technical success was achieved in in 91.18% of cases, stenting was done in 64.51% of cases, and the mean time for the procedure was 73.18 ± 12.96 minutes. ABI significantly increased with clinical improvement. Patency rate at 3, 6, and 12 months were 80%, 56.67%, and 43.33% respectively. While limb salvage rate at 3, 6, and 12 months were 96.67%, 93.33%, and 93.33% respectively.

Conclusion: Native vessel revascularization is a feasible procedure that can be done safely with acceptable technical success and limb salvage rate. It represents a good option for patients who are poor candidates for redo surgery.